Management strategies in persons with inherited haemophilia requiring antithrombotic therapy: A scoping review
Haemophilia · 2024
DOI: 10.1111/hae.14906 ↗Kurz gefasst
Scoping Review in der Zeitschrift Haemophilia, 2024. Verfasst von Kelsey Uminski und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Hematological Malignancies, Department of Medicine, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Hemophilia A, Venous Thromboembolism, Cardiovascular Diseases, Thrombosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Background
Thromboembolic events are increasingly reported in the aging haemophilia population. The purpose of this study was to understand current practices and identify knowledge and research gaps in the management of persons with haemophilia requiring antithrombotic therapy for cardiovascular disorders (CVD) or venous thromboembolism (VTE).
Methods
We searched MEDLINE, EMBASE and Scopus for studies reporting on more than two patients with inherited haemophilia A or B, without inhibitors, requiring antithrombotic therapy for CVD or VTE. Data were extracted by two independent reviewers and analysed using descriptive statistics and narrative synthesis.
Results
We included 32 studies reporting on 432 persons with haemophilia. Three themes described the observed practice variation: (1) Difficulty weighing competing bleeding and thrombotic risks; (2) Tensions in providing standards of care and minimizing bleeding risk; (3) Advocacy for individualized strategies and multidisciplinary care. Different management strategies were used to treat persons with haemophilia in the setting of thromboembolic events, such as avoiding or choosing lower intensity antithrombotic therapy, or procedural alternatives to antithrombotic therapy. Initiation or alteration in haemostatic therapies along with antithrombotic therapy were common strategies and reported in 30 studies. However, data on target factor levels and bleeding and thrombotic events were largely missing.
Discussion
Our scoping review highlights unmet needs in the management of an aging population of persons with haemophilia with increasing prevalence of CVD and VTE. Management is inconsistent and divergent from those of non‐haemophilic patients. Prospective data are needed to inform optimal and evidence‐based management strategies of CVD and VTE in persons with haemophilia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology and Hematological Malignancies, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
- Division of Hematology, Department of Medicine, University of Ottawa at the Ottawa Hospital, Ottawa, Ontario, Canada.
- Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
- Health Sciences Library, University of Ottawa, Ottawa, Ontario, Canada.
ORCID-Profile: Kelsey Uminski, Roy Khalife
Zitieren
APA
Uminski, K., Xu, Y., Zahrai, A., Hodgson, A., Wang, T. F., Duffett, L., Tinmouth, A., & Khalife, R. (2024). Management strategies in persons with inherited haemophilia requiring antithrombotic therapy: A scoping review. Haemophilia. https://doi.org/10.1111/hae.14906
Vancouver
Uminski K, Xu Y, Zahrai A, Hodgson A, Wang TF, Duffett L, et al. Management strategies in persons with inherited haemophilia requiring antithrombotic therapy: A scoping review. Haemophilia. 2024. doi:10.1111/hae.14906
BibTeX
@article{Uminski2024,
author = {Uminski, Kelsey and Xu, Yan and Zahrai, Amin and Hodgson, Amanda and Wang, Tzu-Fei and Duffett, Lisa and Tinmouth, Alan and Khalife, Roy},
title = {Management strategies in persons with inherited haemophilia requiring antithrombotic therapy: A scoping review},
journal = {Haemophilia},
year = {2024},
doi = {10.1111/hae.14906}
}
EUVIMED